<DOC>
	<DOCNO>NCT00578097</DOCNO>
	<brief_summary>The purpose study determine optimal dose botulinum toxin type A injected detrusor muscle improve urinary symptom , urodynamic parameter quality life continent woman suffer idiopathic overactive bladder .</brief_summary>
	<brief_title>Efficacy Safety Study Botulinum Toxin Type-A ( Dysport® ) Continent Female Subjects Suffering From Idiopathic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>The subject diagnosis idiopathic overactive bladder , without incontinence . The subject ≥ 3 urgency episode course 3 day immediately precede Baseline visit . The subject ≥ 24 episode micturition course 3 day immediately precede Baseline visit . Bladder outlet obstruction ( urodynamic assessment ) . PostMicturition Residual Volume &gt; 150 ml ( ultrasound assessment ) . Evidence urinary tract infection Screening Baseline study . Active history interstitial cystitis , malignancy bladder urothelial tract , carcinoma situ ( non malignant melanoma allow ) bladder and/or kidney stone .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>